Advertisement

Index by author

August 01, 1990; Volume 254,Issue 2

A

  1. Adachi, Y

    1. Effect of UDP-glucuronic acid depletion by salicylamide on biliary bilirubin excretion in the rat.
      T Kamisako, Y Adachi and T Yamamoto
      Journal of Pharmacology and Experimental Therapeutics August 1990, 254 (2) 380-382;

  2. Airey, J E

    1. RG 12915: a potent 5-hydroxytryptamine-3 antagonist that is an orally effective inhibitor of cytotoxic drug-induced emesis in the ferret and dog.
      L R Fitzpatrick, R M Lambert, C E Pendley, G E Martin, J S Bostwick, G W Gessner, J E Airey, R D Youssefyeh, R G Pendleton and D L Decktor
      Journal of Pharmacology and Experimental Therapeutics August 1990, 254 (2) 450-455;

  3. Akins, J M

    1. Determination and metabolism of dithiol chelating agents: X. In humans, meso-2,3-dimercaptosuccinic acid is bound to plasma proteins via mixed disulfide formation.
      R M Maiorino, J M Akins, K Blaha, D E Carter and H V Aposhian
      Journal of Pharmacology and Experimental Therapeutics August 1990, 254 (2) 570-577;

  4. Amenta, F

    1. Autoradiographic localization of dopamine DA-2 receptor sites in rat mesenteric vascular tree.
      A Ricci and F Amenta
      Journal of Pharmacology and Experimental Therapeutics August 1990, 254 (2) 750-755;

  5. Aposhian, H V

    1. Determination and metabolism of dithiol chelating agents: X. In humans, meso-2,3-dimercaptosuccinic acid is bound to plasma proteins via mixed disulfide formation.
      R M Maiorino, J M Akins, K Blaha, D E Carter and H V Aposhian
      Journal of Pharmacology and Experimental Therapeutics August 1990, 254 (2) 570-577;

  6. Aronstam, R S

    1. Increased muscarinic responsiveness and decreased muscarinic receptor content in ileal smooth muscle in diabetes.
      G O Carrier and R S Aronstam
      Journal of Pharmacology and Experimental Therapeutics August 1990, 254 (2) 445-449;

  7. Aubineau, P

    1. Effects of methylene blue on hypoxic cerebral vasodilatation in the rabbit.
      W J Pearce, A M Reynier-Rebuffel, J Lee, P Aubineau, L Ignarro and J Seylaz
      Journal of Pharmacology and Experimental Therapeutics August 1990, 254 (2) 616-625;

B

  1. Baeblich, S

    1. Basal and stimulated formation and release of L-arginine-derived nitrogen oxides from cultured endothelial cells.
      H H Schmidt, B Zernikow, S Baeblich and E Böhme
      Journal of Pharmacology and Experimental Therapeutics August 1990, 254 (2) 591-597;

  2. Baretti, R

    1. Alpha-adrenoceptor mediated facilitation of acetylcholine release in the rat perfused heart.
      I T Bognar, R Baretti, S Fischer, C Veldet and H Fuder
      Journal of Pharmacology and Experimental Therapeutics August 1990, 254 (2) 702-710;

  3. Barrett, R J

    1. Adaptation of brain 5HT2 receptors after mianserin treatment: receptor sensitivity, not receptor binding, more accurately correlates with behavior.
      R L Smith, R J Barrett and E Sanders-Bush
      Journal of Pharmacology and Experimental Therapeutics August 1990, 254 (2) 484-488;

  4. Berry, S A

    1. D1 receptors function to inhibit the activation of tuberoinfundibular dopamine neurons.
      S A Berry and G A Gudelsky
      Journal of Pharmacology and Experimental Therapeutics August 1990, 254 (2) 677-682;

  5. Bickel, M H

    1. Single-dose kinetics of tissue distribution, excretion and metabolism of amiodarone in rats.
      P A Wyss, M J Moor and M H Bickel
      Journal of Pharmacology and Experimental Therapeutics August 1990, 254 (2) 502-507;

  6. Bickford-Wimer, P C

    1. Electrophysiological effects of selective D1 and D2 dopamine receptor agonists in the medial prefrontal cortex of young and aged Fischer 344 rats.
      K D Parfitt, A Gratton and P C Bickford-Wimer
      Journal of Pharmacology and Experimental Therapeutics August 1990, 254 (2) 539-545;

  7. Blackmore, P F

    1. Differential activation of rabbit femoral arteries by aluminum fluoride and sodium fluoride.
      P H Ratz and P F Blackmore
      Journal of Pharmacology and Experimental Therapeutics August 1990, 254 (2) 514-520;

  8. Blaha, K

    1. Determination and metabolism of dithiol chelating agents: X. In humans, meso-2,3-dimercaptosuccinic acid is bound to plasma proteins via mixed disulfide formation.
      R M Maiorino, J M Akins, K Blaha, D E Carter and H V Aposhian
      Journal of Pharmacology and Experimental Therapeutics August 1990, 254 (2) 570-577;

  9. Boeckxstaens, G E

    1. Pharmacological characterization of 5-hydroxytryptamine receptors in the canine terminal ileum and ileocolonic junction.
      G E Boeckxstaens, P A Pelckmans, M Rampart, J J Bogers, T J Verbeuren, A G Herman and Y M Van Maercke
      Journal of Pharmacology and Experimental Therapeutics August 1990, 254 (2) 652-658;
    2. Evidence against ATP being the inhibitory transmitter released by nonadrenergic noncholinergic nerves in the canine ileocolonic junction.
      G E Boeckxstaens, P A Pelckmans, M Rampart, T J Verbeuren, A G Herman and Y M Van Maercke
      Journal of Pharmacology and Experimental Therapeutics August 1990, 254 (2) 659-663;

  10. Bogers, J J

    1. Pharmacological characterization of 5-hydroxytryptamine receptors in the canine terminal ileum and ileocolonic junction.
      G E Boeckxstaens, P A Pelckmans, M Rampart, J J Bogers, T J Verbeuren, A G Herman and Y M Van Maercke
      Journal of Pharmacology and Experimental Therapeutics August 1990, 254 (2) 652-658;

  11. Bognar, I T

    1. Alpha-adrenoceptor mediated facilitation of acetylcholine release in the rat perfused heart.
      I T Bognar, R Baretti, S Fischer, C Veldet and H Fuder
      Journal of Pharmacology and Experimental Therapeutics August 1990, 254 (2) 702-710;

  12. Böhme, E

    1. Basal and stimulated formation and release of L-arginine-derived nitrogen oxides from cultured endothelial cells.
      H H Schmidt, B Zernikow, S Baeblich and E Böhme
      Journal of Pharmacology and Experimental Therapeutics August 1990, 254 (2) 591-597;

  13. Bostwick, J S

    1. RG 12915: a potent 5-hydroxytryptamine-3 antagonist that is an orally effective inhibitor of cytotoxic drug-induced emesis in the ferret and dog.
      L R Fitzpatrick, R M Lambert, C E Pendley, G E Martin, J S Bostwick, G W Gessner, J E Airey, R D Youssefyeh, R G Pendleton and D L Decktor
      Journal of Pharmacology and Experimental Therapeutics August 1990, 254 (2) 450-455;

  14. Bowyer, J F

    1. Ca2(+)-evoked [3H]dopamine release from synaptosomes is dependent on neuronal type Ca2+ channels and is not mediated by acetylcholine, glutamate or aspartate release.
      J F Bowyer and N Weiner
      Journal of Pharmacology and Experimental Therapeutics August 1990, 254 (2) 664-670;

  15. Breese, G R

    1. Site-specific enhancement of gamma-aminobutyric acid-mediated inhibition of neural activity by ethanol in the rat medial septal area.
      B S Givens and G R Breese
      Journal of Pharmacology and Experimental Therapeutics August 1990, 254 (2) 528-538;

  16. Brock, T A

    1. Endothelin receptor-coupling mechanisms in vascular smooth muscle: a role for protein kinase C.
      N R Danthuluri and T A Brock
      Journal of Pharmacology and Experimental Therapeutics August 1990, 254 (2) 393-399;

  17. Broderick, P A

    1. U-66444B and U-68553B, potent autoreceptor agonists at dopaminergic cell bodies and terminals.
      M F Piercey, P A Broderick, W E Hoffmann and G D Vogelsang
      Journal of Pharmacology and Experimental Therapeutics August 1990, 254 (2) 369-374;

  18. Brooks, D P

    1. Prevention and complete reversal of cyclosporine A-induced renal vasoconstriction and nephrotoxicity in the rat by fenoldopam.
      D P Brooks, D J Drutz and R R Ruffolo
      Journal of Pharmacology and Experimental Therapeutics August 1990, 254 (2) 375-379;

C

  1. Callaway, C W

    1. Serotonin release contributes to the locomotor stimulant effects of 3,4-methylenedioxymethamphetamine in rats.
      C W Callaway, L L Wing and M A Geyer
      Journal of Pharmacology and Experimental Therapeutics August 1990, 254 (2) 456-464;

  2. Carmeliet, E

    1. Mechanism of cardiac T-type Ca channel blockade by amiloride.
      J Tytgat, J Vereecke and E Carmeliet
      Journal of Pharmacology and Experimental Therapeutics August 1990, 254 (2) 546-551;

  3. Carrier, G O

    1. Increased muscarinic responsiveness and decreased muscarinic receptor content in ileal smooth muscle in diabetes.
      G O Carrier and R S Aronstam
      Journal of Pharmacology and Experimental Therapeutics August 1990, 254 (2) 445-449;

  4. Carter, D E

    1. Determination and metabolism of dithiol chelating agents: X. In humans, meso-2,3-dimercaptosuccinic acid is bound to plasma proteins via mixed disulfide formation.
      R M Maiorino, J M Akins, K Blaha, D E Carter and H V Aposhian
      Journal of Pharmacology and Experimental Therapeutics August 1990, 254 (2) 570-577;

  5. Chalmers, J

    1. Tonic opioid inhibition of the pressor region of the rostral ventrolateral medulla of rabbits is mediated by delta receptors.
      D A Morilak, G Drolet and J Chalmers
      Journal of Pharmacology and Experimental Therapeutics August 1990, 254 (2) 671-676;

  6. Chambers, M A

    1. Bioactivation of 8-methoxypsoralen and irreversible inactivation of cytochrome P-450 in mouse liver microsomes: modification by monoclonal antibodies, inhibition of drug metabolism and distribution of covalent adducts.
      D C Mays, J B Hilliard, D D Wong, M A Chambers, S S Park, H V Gelboin and N Gerber
      Journal of Pharmacology and Experimental Therapeutics August 1990, 254 (2) 720-731;

  7. Cho, A K

    1. Metabolism of methylenedioxymethamphetamine: formation of dihydroxymethamphetamine and a quinone identified as its glutathione adduct.
      M Hiramatsu, Y Kumagai, S E Unger and A K Cho
      Journal of Pharmacology and Experimental Therapeutics August 1990, 254 (2) 521-527;

  8. Cicero, T J

    1. Affinity of drugs and peptides for U-69,593-sensitive and -insensitive kappa opiate binding sites: the U-69,593-insensitive site appears to be the beta endorphin-specific epsilon receptor.
      B Nock, A L Giordano, T J Cicero and L H O'Connor
      Journal of Pharmacology and Experimental Therapeutics August 1990, 254 (2) 412-419;

  9. Cleemann, L

    1. Tedisamil blocks the transient and delayed rectifier K+ currents in mammalian cardiac and glial cells.
      I D Dukes, L Cleemann and M Morad
      Journal of Pharmacology and Experimental Therapeutics August 1990, 254 (2) 560-569;

  10. Covey, D F

    1. Binding interactions of convulsant and anticonvulsant gamma-butyrolactones and gamma-thiobutyrolactones with the picrotoxin receptor.
      K D Holland, A C McKeon, D F Covey and J A Ferrendelli
      Journal of Pharmacology and Experimental Therapeutics August 1990, 254 (2) 578-583;

D

  1. Daniel, E E

    1. Characterization of the prejunctional beta adrenoceptors in canine bronchial smooth muscle.
      L J Janssen and E E Daniel
      Journal of Pharmacology and Experimental Therapeutics August 1990, 254 (2) 741-749;

  2. Danthuluri, N R

    1. Endothelin receptor-coupling mechanisms in vascular smooth muscle: a role for protein kinase C.
      N R Danthuluri and T A Brock
      Journal of Pharmacology and Experimental Therapeutics August 1990, 254 (2) 393-399;

  3. Decktor, D L

    1. RG 12915: a potent 5-hydroxytryptamine-3 antagonist that is an orally effective inhibitor of cytotoxic drug-induced emesis in the ferret and dog.
      L R Fitzpatrick, R M Lambert, C E Pendley, G E Martin, J S Bostwick, G W Gessner, J E Airey, R D Youssefyeh, R G Pendleton and D L Decktor
      Journal of Pharmacology and Experimental Therapeutics August 1990, 254 (2) 450-455;

  4. De Vane, C L

    1. Effects of benzoyltropine and tropacocaine on several cholinergic processes in the rat brain.
      E M Meyer, L T Potter, C L De Vane, I Irwin, S L MacKay, R Miller and A J Ruttenber
      Journal of Pharmacology and Experimental Therapeutics August 1990, 254 (2) 584-590;

  5. Drolet, G

    1. Tonic opioid inhibition of the pressor region of the rostral ventrolateral medulla of rabbits is mediated by delta receptors.
      D A Morilak, G Drolet and J Chalmers
      Journal of Pharmacology and Experimental Therapeutics August 1990, 254 (2) 671-676;

  6. Drutz, D J

    1. Prevention and complete reversal of cyclosporine A-induced renal vasoconstriction and nephrotoxicity in the rat by fenoldopam.
      D P Brooks, D J Drutz and R R Ruffolo
      Journal of Pharmacology and Experimental Therapeutics August 1990, 254 (2) 375-379;

  7. Dukes, I D

    1. Tedisamil blocks the transient and delayed rectifier K+ currents in mammalian cardiac and glial cells.
      I D Dukes, L Cleemann and M Morad
      Journal of Pharmacology and Experimental Therapeutics August 1990, 254 (2) 560-569;

E

  1. Effeney, D J

    1. Efficacy of single or repeated hemoperfusion in a canine model of paraquat poisoning.
      E C Hampson, D J Effeney and S M Pond
      Journal of Pharmacology and Experimental Therapeutics August 1990, 254 (2) 732-740;

  2. Ellingboe, J

    1. Alcohol effects on hCG-stimulated gonadal hormones in women.
      S K Teoh, J H Mendelson, N K Mello, A Skupny and J Ellingboe
      Journal of Pharmacology and Experimental Therapeutics August 1990, 254 (2) 407-411;

F

  1. Ferraino, R

    1. In vivo assessment of napamezole, an alpha-2 adrenoceptor antagonist and monoamine re-uptake inhibitor.
      M H Perrone, D Luttinger, L T Hamel, P M Fritz, R Ferraino and D R Haubrich
      Journal of Pharmacology and Experimental Therapeutics August 1990, 254 (2) 476-483;

  2. Ferrari, R A

    1. Napamezole, an alpha-2 adrenergic receptor antagonist and monoamine uptake inhibitor in vitro.
      M H Perrone, L T Hamel, R A Ferrari and D R Haubrich
      Journal of Pharmacology and Experimental Therapeutics August 1990, 254 (2) 471-475;

  3. Ferrendelli, J A

    1. Binding interactions of convulsant and anticonvulsant gamma-butyrolactones and gamma-thiobutyrolactones with the picrotoxin receptor.
      K D Holland, A C McKeon, D F Covey and J A Ferrendelli
      Journal of Pharmacology and Experimental Therapeutics August 1990, 254 (2) 578-583;

  4. Fischer, S

    1. Alpha-adrenoceptor mediated facilitation of acetylcholine release in the rat perfused heart.
      I T Bognar, R Baretti, S Fischer, C Veldet and H Fuder
      Journal of Pharmacology and Experimental Therapeutics August 1990, 254 (2) 702-710;

  5. Fitzpatrick, L R

    1. RG 12915: a potent 5-hydroxytryptamine-3 antagonist that is an orally effective inhibitor of cytotoxic drug-induced emesis in the ferret and dog.
      L R Fitzpatrick, R M Lambert, C E Pendley, G E Martin, J S Bostwick, G W Gessner, J E Airey, R D Youssefyeh, R G Pendleton and D L Decktor
      Journal of Pharmacology and Experimental Therapeutics August 1990, 254 (2) 450-455;

  6. Foth, H

    1. Nonlinear elimination kinetics of 5-fluoro-2'-deoxyuridine in isolated perfused rat liver and isolated hepatocytes.
      H Foth, E M Kunellis, T Müseler and G F Kahl
      Journal of Pharmacology and Experimental Therapeutics August 1990, 254 (2) 427-432;

  7. France, C P

    1. Discriminative stimulus effects of opioid agonists in morphine-dependent pigeons.
      C P France and J H Woods
      Journal of Pharmacology and Experimental Therapeutics August 1990, 254 (2) 626-632;

  8. Fritz, P M

    1. In vivo assessment of napamezole, an alpha-2 adrenoceptor antagonist and monoamine re-uptake inhibitor.
      M H Perrone, D Luttinger, L T Hamel, P M Fritz, R Ferraino and D R Haubrich
      Journal of Pharmacology and Experimental Therapeutics August 1990, 254 (2) 476-483;

  9. Fuder, H

    1. Alpha-adrenoceptor mediated facilitation of acetylcholine release in the rat perfused heart.
      I T Bognar, R Baretti, S Fischer, C Veldet and H Fuder
      Journal of Pharmacology and Experimental Therapeutics August 1990, 254 (2) 702-710;

  10. Fyhrquist, F

    1. Elevation of plasma atrial natriuretic peptide in rats with chronic heart failure by SCH 39370, a neutral metalloendopeptidase inhibitor.
      I Tikkanen, K Helin, T Tikkanen, E J Sybertz, S Vemulapalli, H Sariola, H Näveri and F Fyhrquist
      Journal of Pharmacology and Experimental Therapeutics August 1990, 254 (2) 641-645;

G

  1. Gelboin, H V

    1. Bioactivation of 8-methoxypsoralen and irreversible inactivation of cytochrome P-450 in mouse liver microsomes: modification by monoclonal antibodies, inhibition of drug metabolism and distribution of covalent adducts.
      D C Mays, J B Hilliard, D D Wong, M A Chambers, S S Park, H V Gelboin and N Gerber
      Journal of Pharmacology and Experimental Therapeutics August 1990, 254 (2) 720-731;

  2. Gerber, N

    1. Bioactivation of 8-methoxypsoralen and irreversible inactivation of cytochrome P-450 in mouse liver microsomes: modification by monoclonal antibodies, inhibition of drug metabolism and distribution of covalent adducts.
      D C Mays, J B Hilliard, D D Wong, M A Chambers, S S Park, H V Gelboin and N Gerber
      Journal of Pharmacology and Experimental Therapeutics August 1990, 254 (2) 720-731;

  3. Gessner, G W

    1. RG 12915: a potent 5-hydroxytryptamine-3 antagonist that is an orally effective inhibitor of cytotoxic drug-induced emesis in the ferret and dog.
      L R Fitzpatrick, R M Lambert, C E Pendley, G E Martin, J S Bostwick, G W Gessner, J E Airey, R D Youssefyeh, R G Pendleton and D L Decktor
      Journal of Pharmacology and Experimental Therapeutics August 1990, 254 (2) 450-455;

  4. Geyer, M A

    1. Serotonin release contributes to the locomotor stimulant effects of 3,4-methylenedioxymethamphetamine in rats.
      C W Callaway, L L Wing and M A Geyer
      Journal of Pharmacology and Experimental Therapeutics August 1990, 254 (2) 456-464;

  5. Giordano, A L

    1. Affinity of drugs and peptides for U-69,593-sensitive and -insensitive kappa opiate binding sites: the U-69,593-insensitive site appears to be the beta endorphin-specific epsilon receptor.
      B Nock, A L Giordano, T J Cicero and L H O'Connor
      Journal of Pharmacology and Experimental Therapeutics August 1990, 254 (2) 412-419;

  6. Givens, B S

    1. Site-specific enhancement of gamma-aminobutyric acid-mediated inhibition of neural activity by ethanol in the rat medial septal area.
      B S Givens and G R Breese
      Journal of Pharmacology and Experimental Therapeutics August 1990, 254 (2) 528-538;

  7. Granneman, J G

    1. Norepinephrine and BRL 37344 stimulate adenylate cyclase by different receptors in rat brown adipose tissue.
      J G Granneman
      Journal of Pharmacology and Experimental Therapeutics August 1990, 254 (2) 508-513;

  8. Gratton, A

    1. Electrophysiological effects of selective D1 and D2 dopamine receptor agonists in the medial prefrontal cortex of young and aged Fischer 344 rats.
      K D Parfitt, A Gratton and P C Bickford-Wimer
      Journal of Pharmacology and Experimental Therapeutics August 1990, 254 (2) 539-545;

  9. Gudelsky, G A

    1. D1 receptors function to inhibit the activation of tuberoinfundibular dopamine neurons.
      S A Berry and G A Gudelsky
      Journal of Pharmacology and Experimental Therapeutics August 1990, 254 (2) 677-682;

  10. Guenaneche, F

    1. Influence of the DA2-receptor agonist quinpirole on the guinea pig ileum.
      F Guenaneche and R A Lefebvre
      Journal of Pharmacology and Experimental Therapeutics August 1990, 254 (2) 489-495;

H

  1. Hamel, L T

    1. Napamezole, an alpha-2 adrenergic receptor antagonist and monoamine uptake inhibitor in vitro.
      M H Perrone, L T Hamel, R A Ferrari and D R Haubrich
      Journal of Pharmacology and Experimental Therapeutics August 1990, 254 (2) 471-475;
    2. In vivo assessment of napamezole, an alpha-2 adrenoceptor antagonist and monoamine re-uptake inhibitor.
      M H Perrone, D Luttinger, L T Hamel, P M Fritz, R Ferraino and D R Haubrich
      Journal of Pharmacology and Experimental Therapeutics August 1990, 254 (2) 476-483;

  2. Hampson, E C

    1. Efficacy of single or repeated hemoperfusion in a canine model of paraquat poisoning.
      E C Hampson, D J Effeney and S M Pond
      Journal of Pharmacology and Experimental Therapeutics August 1990, 254 (2) 732-740;

  3. Hashiba, Y

    1. Effect of a new Ca2(+)-calmodulin-dependent protein kinase II inhibitor on GABA release in cerebrospinal fluid of the rat.
      N Ishikawa, Y Hashiba and H Hidaka
      Journal of Pharmacology and Experimental Therapeutics August 1990, 254 (2) 598-602;

  4. Haubrich, D R

    1. Napamezole, an alpha-2 adrenergic receptor antagonist and monoamine uptake inhibitor in vitro.
      M H Perrone, L T Hamel, R A Ferrari and D R Haubrich
      Journal of Pharmacology and Experimental Therapeutics August 1990, 254 (2) 471-475;
    2. In vivo assessment of napamezole, an alpha-2 adrenoceptor antagonist and monoamine re-uptake inhibitor.
      M H Perrone, D Luttinger, L T Hamel, P M Fritz, R Ferraino and D R Haubrich
      Journal of Pharmacology and Experimental Therapeutics August 1990, 254 (2) 476-483;

  5. Hayashi, H

    1. Novel cardioprotective effects of TYB-3823 on ischemic damage in the working hearts of rats: comparison with lidocaine.
      T Ohmura, I Muramatsu, S Kigoshi, H Noguchi, R Muraoka, Y Komoriya and H Hayashi
      Journal of Pharmacology and Experimental Therapeutics August 1990, 254 (2) 696-701;

  6. Helin, K

    1. Elevation of plasma atrial natriuretic peptide in rats with chronic heart failure by SCH 39370, a neutral metalloendopeptidase inhibitor.
      I Tikkanen, K Helin, T Tikkanen, E J Sybertz, S Vemulapalli, H Sariola, H Näveri and F Fyhrquist
      Journal of Pharmacology and Experimental Therapeutics August 1990, 254 (2) 641-645;

  7. Herman, A G

    1. Pharmacological characterization of 5-hydroxytryptamine receptors in the canine terminal ileum and ileocolonic junction.
      G E Boeckxstaens, P A Pelckmans, M Rampart, J J Bogers, T J Verbeuren, A G Herman and Y M Van Maercke
      Journal of Pharmacology and Experimental Therapeutics August 1990, 254 (2) 652-658;
    2. Evidence against ATP being the inhibitory transmitter released by nonadrenergic noncholinergic nerves in the canine ileocolonic junction.
      G E Boeckxstaens, P A Pelckmans, M Rampart, T J Verbeuren, A G Herman and Y M Van Maercke
      Journal of Pharmacology and Experimental Therapeutics August 1990, 254 (2) 659-663;

  8. Hidaka, H

    1. Effect of a new Ca2(+)-calmodulin-dependent protein kinase II inhibitor on GABA release in cerebrospinal fluid of the rat.
      N Ishikawa, Y Hashiba and H Hidaka
      Journal of Pharmacology and Experimental Therapeutics August 1990, 254 (2) 598-602;

  9. Hill, M

    1. Halothane increases cytosolic Ca2+ and inhibits Na+/H+ exchange in L6 muscle cells.
      A Klip, M Hill and T Ramlal
      Journal of Pharmacology and Experimental Therapeutics August 1990, 254 (2) 552-559;

  10. Hilliard, J B

    1. Bioactivation of 8-methoxypsoralen and irreversible inactivation of cytochrome P-450 in mouse liver microsomes: modification by monoclonal antibodies, inhibition of drug metabolism and distribution of covalent adducts.
      D C Mays, J B Hilliard, D D Wong, M A Chambers, S S Park, H V Gelboin and N Gerber
      Journal of Pharmacology and Experimental Therapeutics August 1990, 254 (2) 720-731;

  11. Hiramatsu, M

    1. Metabolism of methylenedioxymethamphetamine: formation of dihydroxymethamphetamine and a quinone identified as its glutathione adduct.
      M Hiramatsu, Y Kumagai, S E Unger and A K Cho
      Journal of Pharmacology and Experimental Therapeutics August 1990, 254 (2) 521-527;

  12. Hoffmann, W E

    1. U-66444B and U-68553B, potent autoreceptor agonists at dopaminergic cell bodies and terminals.
      M F Piercey, P A Broderick, W E Hoffmann and G D Vogelsang
      Journal of Pharmacology and Experimental Therapeutics August 1990, 254 (2) 369-374;

  13. Holland, K D

    1. Binding interactions of convulsant and anticonvulsant gamma-butyrolactones and gamma-thiobutyrolactones with the picrotoxin receptor.
      K D Holland, A C McKeon, D F Covey and J A Ferrendelli
      Journal of Pharmacology and Experimental Therapeutics August 1990, 254 (2) 578-583;

I

  1. Ignarro, L

    1. Effects of methylene blue on hypoxic cerebral vasodilatation in the rabbit.
      W J Pearce, A M Reynier-Rebuffel, J Lee, P Aubineau, L Ignarro and J Seylaz
      Journal of Pharmacology and Experimental Therapeutics August 1990, 254 (2) 616-625;

  2. Irwin, I

    1. Effects of benzoyltropine and tropacocaine on several cholinergic processes in the rat brain.
      E M Meyer, L T Potter, C L De Vane, I Irwin, S L MacKay, R Miller and A J Ruttenber
      Journal of Pharmacology and Experimental Therapeutics August 1990, 254 (2) 584-590;

  3. Ishikawa, N

    1. Effect of a new Ca2(+)-calmodulin-dependent protein kinase II inhibitor on GABA release in cerebrospinal fluid of the rat.
      N Ishikawa, Y Hashiba and H Hidaka
      Journal of Pharmacology and Experimental Therapeutics August 1990, 254 (2) 598-602;

J

  1. Janssen, L J

    1. Characterization of the prejunctional beta adrenoceptors in canine bronchial smooth muscle.
      L J Janssen and E E Daniel
      Journal of Pharmacology and Experimental Therapeutics August 1990, 254 (2) 741-749;

K

  1. Kahl, G F

    1. Nonlinear elimination kinetics of 5-fluoro-2'-deoxyuridine in isolated perfused rat liver and isolated hepatocytes.
      H Foth, E M Kunellis, T Müseler and G F Kahl
      Journal of Pharmacology and Experimental Therapeutics August 1990, 254 (2) 427-432;

  2. Kalivas, P W

    1. Effect of microinjections of apamin into the A10 dopamine region of rats: a behavioral and neurochemical analysis.
      J D Steketee and P W Kalivas
      Journal of Pharmacology and Experimental Therapeutics August 1990, 254 (2) 711-719;

  3. Kamisako, T

    1. Effect of UDP-glucuronic acid depletion by salicylamide on biliary bilirubin excretion in the rat.
      T Kamisako, Y Adachi and T Yamamoto
      Journal of Pharmacology and Experimental Therapeutics August 1990, 254 (2) 380-382;

  4. Kigoshi, S

    1. Novel cardioprotective effects of TYB-3823 on ischemic damage in the working hearts of rats: comparison with lidocaine.
      T Ohmura, I Muramatsu, S Kigoshi, H Noguchi, R Muraoka, Y Komoriya and H Hayashi
      Journal of Pharmacology and Experimental Therapeutics August 1990, 254 (2) 696-701;

  5. Klip, A

    1. Halothane increases cytosolic Ca2+ and inhibits Na+/H+ exchange in L6 muscle cells.
      A Klip, M Hill and T Ramlal
      Journal of Pharmacology and Experimental Therapeutics August 1990, 254 (2) 552-559;

  6. Koch, R L

    1. The anaerobic metabolism of verapamil in rat cecal contents forms nor-verapamil and thiocyanate.
      R L Koch and P Palicharla
      Journal of Pharmacology and Experimental Therapeutics August 1990, 254 (2) 612-615;

  7. Komoriya, Y

    1. Novel cardioprotective effects of TYB-3823 on ischemic damage in the working hearts of rats: comparison with lidocaine.
      T Ohmura, I Muramatsu, S Kigoshi, H Noguchi, R Muraoka, Y Komoriya and H Hayashi
      Journal of Pharmacology and Experimental Therapeutics August 1990, 254 (2) 696-701;

  8. Koplovitz, I

    1. Effect of endogenous carboxylesterase on HI-6 protection against soman toxicity.
      D M Maxwell and I Koplovitz
      Journal of Pharmacology and Experimental Therapeutics August 1990, 254 (2) 440-444;

  9. Krause, J E

    1. Compensatory activation of substance P biosynthesis by L-dihydroxyphenylalanine in striatonigral neurons of neonatal dopaminergic denervated rats.
      S P Sivam and J E Krause
      Journal of Pharmacology and Experimental Therapeutics August 1990, 254 (2) 433-439;

  10. Kumagai, Y

    1. Metabolism of methylenedioxymethamphetamine: formation of dihydroxymethamphetamine and a quinone identified as its glutathione adduct.
      M Hiramatsu, Y Kumagai, S E Unger and A K Cho
      Journal of Pharmacology and Experimental Therapeutics August 1990, 254 (2) 521-527;

  11. Kunellis, E M

    1. Nonlinear elimination kinetics of 5-fluoro-2'-deoxyuridine in isolated perfused rat liver and isolated hepatocytes.
      H Foth, E M Kunellis, T Müseler and G F Kahl
      Journal of Pharmacology and Experimental Therapeutics August 1990, 254 (2) 427-432;

L

  1. Lambert, R M

    1. RG 12915: a potent 5-hydroxytryptamine-3 antagonist that is an orally effective inhibitor of cytotoxic drug-induced emesis in the ferret and dog.
      L R Fitzpatrick, R M Lambert, C E Pendley, G E Martin, J S Bostwick, G W Gessner, J E Airey, R D Youssefyeh, R G Pendleton and D L Decktor
      Journal of Pharmacology and Experimental Therapeutics August 1990, 254 (2) 450-455;

  2. Lautt, W W

    1. Noncompetitive antagonism of adenosine by caffeine on the hepatic and superior mesenteric arteries of anesthetized cats.
      W W Lautt
      Journal of Pharmacology and Experimental Therapeutics August 1990, 254 (2) 400-406;

  3. Lee, J

    1. Effects of methylene blue on hypoxic cerebral vasodilatation in the rabbit.
      W J Pearce, A M Reynier-Rebuffel, J Lee, P Aubineau, L Ignarro and J Seylaz
      Journal of Pharmacology and Experimental Therapeutics August 1990, 254 (2) 616-625;

  4. Lefebvre, R A

    1. Influence of the DA2-receptor agonist quinpirole on the guinea pig ileum.
      F Guenaneche and R A Lefebvre
      Journal of Pharmacology and Experimental Therapeutics August 1990, 254 (2) 489-495;

  5. Leppäluoto, J

    1. Mechanism of opioid-induced atrial natriuretic peptide release in conscious rats.
      A Pesonen, J Leppäluoto and H Ruskoaho
      Journal of Pharmacology and Experimental Therapeutics August 1990, 254 (2) 690-695;

  6. Luttinger, D

    1. In vivo assessment of napamezole, an alpha-2 adrenoceptor antagonist and monoamine re-uptake inhibitor.
      M H Perrone, D Luttinger, L T Hamel, P M Fritz, R Ferraino and D R Haubrich
      Journal of Pharmacology and Experimental Therapeutics August 1990, 254 (2) 476-483;

M

  1. MacKay, S L

    1. Effects of benzoyltropine and tropacocaine on several cholinergic processes in the rat brain.
      E M Meyer, L T Potter, C L De Vane, I Irwin, S L MacKay, R Miller and A J Ruttenber
      Journal of Pharmacology and Experimental Therapeutics August 1990, 254 (2) 584-590;

  2. Maiorino, R M

    1. Determination and metabolism of dithiol chelating agents: X. In humans, meso-2,3-dimercaptosuccinic acid is bound to plasma proteins via mixed disulfide formation.
      R M Maiorino, J M Akins, K Blaha, D E Carter and H V Aposhian
      Journal of Pharmacology and Experimental Therapeutics August 1990, 254 (2) 570-577;

  3. Malik, K U

    1. Prostaglandin synthesis elicited by adrenergic stimuli in rabbit aorta is mediated via alpha-1 and alpha-2 adrenergic receptors.
      C Nebigil and K U Malik
      Journal of Pharmacology and Experimental Therapeutics August 1990, 254 (2) 633-640;

  4. Marchi, M

    1. Muscarinic receptors mediating inhibition of gamma-aminobutyric acid release in rat corpus striatum and their pharmacological characterization.
      M Raiteri, M Marchi, P Paudice and A Pittaluga
      Journal of Pharmacology and Experimental Therapeutics August 1990, 254 (2) 496-501;

  5. Martin, G E

    1. RG 12915: a potent 5-hydroxytryptamine-3 antagonist that is an orally effective inhibitor of cytotoxic drug-induced emesis in the ferret and dog.
      L R Fitzpatrick, R M Lambert, C E Pendley, G E Martin, J S Bostwick, G W Gessner, J E Airey, R D Youssefyeh, R G Pendleton and D L Decktor
      Journal of Pharmacology and Experimental Therapeutics August 1990, 254 (2) 450-455;

  6. Maxwell, D M

    1. Effect of endogenous carboxylesterase on HI-6 protection against soman toxicity.
      D M Maxwell and I Koplovitz
      Journal of Pharmacology and Experimental Therapeutics August 1990, 254 (2) 440-444;

  7. Mays, D C

    1. Bioactivation of 8-methoxypsoralen and irreversible inactivation of cytochrome P-450 in mouse liver microsomes: modification by monoclonal antibodies, inhibition of drug metabolism and distribution of covalent adducts.
      D C Mays, J B Hilliard, D D Wong, M A Chambers, S S Park, H V Gelboin and N Gerber
      Journal of Pharmacology and Experimental Therapeutics August 1990, 254 (2) 720-731;

  8. McKeon, A C

    1. Binding interactions of convulsant and anticonvulsant gamma-butyrolactones and gamma-thiobutyrolactones with the picrotoxin receptor.
      K D Holland, A C McKeon, D F Covey and J A Ferrendelli
      Journal of Pharmacology and Experimental Therapeutics August 1990, 254 (2) 578-583;

  9. Mello, N K

    1. Alcohol effects on hCG-stimulated gonadal hormones in women.
      S K Teoh, J H Mendelson, N K Mello, A Skupny and J Ellingboe
      Journal of Pharmacology and Experimental Therapeutics August 1990, 254 (2) 407-411;

  10. Mendelson, J H

    1. Alcohol effects on hCG-stimulated gonadal hormones in women.
      S K Teoh, J H Mendelson, N K Mello, A Skupny and J Ellingboe
      Journal of Pharmacology and Experimental Therapeutics August 1990, 254 (2) 407-411;

  11. Meyer, E M

    1. Effects of benzoyltropine and tropacocaine on several cholinergic processes in the rat brain.
      E M Meyer, L T Potter, C L De Vane, I Irwin, S L MacKay, R Miller and A J Ruttenber
      Journal of Pharmacology and Experimental Therapeutics August 1990, 254 (2) 584-590;

  12. Miller, R

    1. Effects of benzoyltropine and tropacocaine on several cholinergic processes in the rat brain.
      E M Meyer, L T Potter, C L De Vane, I Irwin, S L MacKay, R Miller and A J Ruttenber
      Journal of Pharmacology and Experimental Therapeutics August 1990, 254 (2) 584-590;

  13. Monasky, M S

    1. Interaction of intrathecal morphine and ST-91 on antinociception in the rat: dose-response analysis, antagonism and clearance.
      M S Monasky, A R Zinsmeister, C W Stevens and T L Yaksh
      Journal of Pharmacology and Experimental Therapeutics August 1990, 254 (2) 383-392;

  14. Moor, M J

    1. Single-dose kinetics of tissue distribution, excretion and metabolism of amiodarone in rats.
      P A Wyss, M J Moor and M H Bickel
      Journal of Pharmacology and Experimental Therapeutics August 1990, 254 (2) 502-507;

  15. Morad, M

    1. Tedisamil blocks the transient and delayed rectifier K+ currents in mammalian cardiac and glial cells.
      I D Dukes, L Cleemann and M Morad
      Journal of Pharmacology and Experimental Therapeutics August 1990, 254 (2) 560-569;

  16. Morilak, D A

    1. Tonic opioid inhibition of the pressor region of the rostral ventrolateral medulla of rabbits is mediated by delta receptors.
      D A Morilak, G Drolet and J Chalmers
      Journal of Pharmacology and Experimental Therapeutics August 1990, 254 (2) 671-676;

  17. Mosberg, H I

    1. Modulation of the potency and efficacy of mu-mediated antinociception by delta agonists in the mouse.
      J N Qi, H I Mosberg and F Porreca
      Journal of Pharmacology and Experimental Therapeutics August 1990, 254 (2) 683-689;

  18. Muramatsu, I

    1. Novel cardioprotective effects of TYB-3823 on ischemic damage in the working hearts of rats: comparison with lidocaine.
      T Ohmura, I Muramatsu, S Kigoshi, H Noguchi, R Muraoka, Y Komoriya and H Hayashi
      Journal of Pharmacology and Experimental Therapeutics August 1990, 254 (2) 696-701;

  19. Muraoka, R

    1. Novel cardioprotective effects of TYB-3823 on ischemic damage in the working hearts of rats: comparison with lidocaine.
      T Ohmura, I Muramatsu, S Kigoshi, H Noguchi, R Muraoka, Y Komoriya and H Hayashi
      Journal of Pharmacology and Experimental Therapeutics August 1990, 254 (2) 696-701;

  20. Müseler, T

    1. Nonlinear elimination kinetics of 5-fluoro-2'-deoxyuridine in isolated perfused rat liver and isolated hepatocytes.
      H Foth, E M Kunellis, T Müseler and G F Kahl
      Journal of Pharmacology and Experimental Therapeutics August 1990, 254 (2) 427-432;

N

  1. Näveri, H

    1. Elevation of plasma atrial natriuretic peptide in rats with chronic heart failure by SCH 39370, a neutral metalloendopeptidase inhibitor.
      I Tikkanen, K Helin, T Tikkanen, E J Sybertz, S Vemulapalli, H Sariola, H Näveri and F Fyhrquist
      Journal of Pharmacology and Experimental Therapeutics August 1990, 254 (2) 641-645;

  2. Nebigil, C

    1. Prostaglandin synthesis elicited by adrenergic stimuli in rabbit aorta is mediated via alpha-1 and alpha-2 adrenergic receptors.
      C Nebigil and K U Malik
      Journal of Pharmacology and Experimental Therapeutics August 1990, 254 (2) 633-640;

  3. Niida, H

    1. Characterization of alkaline response induced by cholinergic agents in the rat duodenum: involvement of M2 receptors and the calcium-dependent process.
      K Takeuchi, H Niida and S Okabe
      Journal of Pharmacology and Experimental Therapeutics August 1990, 254 (2) 465-470;

  4. Nock, B

    1. Affinity of drugs and peptides for U-69,593-sensitive and -insensitive kappa opiate binding sites: the U-69,593-insensitive site appears to be the beta endorphin-specific epsilon receptor.
      B Nock, A L Giordano, T J Cicero and L H O'Connor
      Journal of Pharmacology and Experimental Therapeutics August 1990, 254 (2) 412-419;

  5. Noguchi, H

    1. Novel cardioprotective effects of TYB-3823 on ischemic damage in the working hearts of rats: comparison with lidocaine.
      T Ohmura, I Muramatsu, S Kigoshi, H Noguchi, R Muraoka, Y Komoriya and H Hayashi
      Journal of Pharmacology and Experimental Therapeutics August 1990, 254 (2) 696-701;

O

  1. O'Connor, L H

    1. Affinity of drugs and peptides for U-69,593-sensitive and -insensitive kappa opiate binding sites: the U-69,593-insensitive site appears to be the beta endorphin-specific epsilon receptor.
      B Nock, A L Giordano, T J Cicero and L H O'Connor
      Journal of Pharmacology and Experimental Therapeutics August 1990, 254 (2) 412-419;

  2. Ohmura, T

    1. Novel cardioprotective effects of TYB-3823 on ischemic damage in the working hearts of rats: comparison with lidocaine.
      T Ohmura, I Muramatsu, S Kigoshi, H Noguchi, R Muraoka, Y Komoriya and H Hayashi
      Journal of Pharmacology and Experimental Therapeutics August 1990, 254 (2) 696-701;

  3. Okabe, S

    1. Characterization of alkaline response induced by cholinergic agents in the rat duodenum: involvement of M2 receptors and the calcium-dependent process.
      K Takeuchi, H Niida and S Okabe
      Journal of Pharmacology and Experimental Therapeutics August 1990, 254 (2) 465-470;

P

  1. Palicharla, P

    1. The anaerobic metabolism of verapamil in rat cecal contents forms nor-verapamil and thiocyanate.
      R L Koch and P Palicharla
      Journal of Pharmacology and Experimental Therapeutics August 1990, 254 (2) 612-615;

  2. Parfitt, K D

    1. Electrophysiological effects of selective D1 and D2 dopamine receptor agonists in the medial prefrontal cortex of young and aged Fischer 344 rats.
      K D Parfitt, A Gratton and P C Bickford-Wimer
      Journal of Pharmacology and Experimental Therapeutics August 1990, 254 (2) 539-545;

  3. Park, S S

    1. Bioactivation of 8-methoxypsoralen and irreversible inactivation of cytochrome P-450 in mouse liver microsomes: modification by monoclonal antibodies, inhibition of drug metabolism and distribution of covalent adducts.
      D C Mays, J B Hilliard, D D Wong, M A Chambers, S S Park, H V Gelboin and N Gerber
      Journal of Pharmacology and Experimental Therapeutics August 1990, 254 (2) 720-731;

  4. Paudice, P

    1. Muscarinic receptors mediating inhibition of gamma-aminobutyric acid release in rat corpus striatum and their pharmacological characterization.
      M Raiteri, M Marchi, P Paudice and A Pittaluga
      Journal of Pharmacology and Experimental Therapeutics August 1990, 254 (2) 496-501;

  5. Pearce, W J

    1. Effects of methylene blue on hypoxic cerebral vasodilatation in the rabbit.
      W J Pearce, A M Reynier-Rebuffel, J Lee, P Aubineau, L Ignarro and J Seylaz
      Journal of Pharmacology and Experimental Therapeutics August 1990, 254 (2) 616-625;

  6. Pelckmans, P A

    1. Pharmacological characterization of 5-hydroxytryptamine receptors in the canine terminal ileum and ileocolonic junction.
      G E Boeckxstaens, P A Pelckmans, M Rampart, J J Bogers, T J Verbeuren, A G Herman and Y M Van Maercke
      Journal of Pharmacology and Experimental Therapeutics August 1990, 254 (2) 652-658;
    2. Evidence against ATP being the inhibitory transmitter released by nonadrenergic noncholinergic nerves in the canine ileocolonic junction.
      G E Boeckxstaens, P A Pelckmans, M Rampart, T J Verbeuren, A G Herman and Y M Van Maercke
      Journal of Pharmacology and Experimental Therapeutics August 1990, 254 (2) 659-663;

  7. Pendleton, R G

    1. RG 12915: a potent 5-hydroxytryptamine-3 antagonist that is an orally effective inhibitor of cytotoxic drug-induced emesis in the ferret and dog.
      L R Fitzpatrick, R M Lambert, C E Pendley, G E Martin, J S Bostwick, G W Gessner, J E Airey, R D Youssefyeh, R G Pendleton and D L Decktor
      Journal of Pharmacology and Experimental Therapeutics August 1990, 254 (2) 450-455;

  8. Pendley, C E

    1. RG 12915: a potent 5-hydroxytryptamine-3 antagonist that is an orally effective inhibitor of cytotoxic drug-induced emesis in the ferret and dog.
      L R Fitzpatrick, R M Lambert, C E Pendley, G E Martin, J S Bostwick, G W Gessner, J E Airey, R D Youssefyeh, R G Pendleton and D L Decktor
      Journal of Pharmacology and Experimental Therapeutics August 1990, 254 (2) 450-455;

  9. Perrone, M H

    1. Napamezole, an alpha-2 adrenergic receptor antagonist and monoamine uptake inhibitor in vitro.
      M H Perrone, L T Hamel, R A Ferrari and D R Haubrich
      Journal of Pharmacology and Experimental Therapeutics August 1990, 254 (2) 471-475;
    2. In vivo assessment of napamezole, an alpha-2 adrenoceptor antagonist and monoamine re-uptake inhibitor.
      M H Perrone, D Luttinger, L T Hamel, P M Fritz, R Ferraino and D R Haubrich
      Journal of Pharmacology and Experimental Therapeutics August 1990, 254 (2) 476-483;

  10. Pesonen, A

    1. Mechanism of opioid-induced atrial natriuretic peptide release in conscious rats.
      A Pesonen, J Leppäluoto and H Ruskoaho
      Journal of Pharmacology and Experimental Therapeutics August 1990, 254 (2) 690-695;

  11. Piercey, M F

    1. U-66444B and U-68553B, potent autoreceptor agonists at dopaminergic cell bodies and terminals.
      M F Piercey, P A Broderick, W E Hoffmann and G D Vogelsang
      Journal of Pharmacology and Experimental Therapeutics August 1990, 254 (2) 369-374;

  12. Pittaluga, A

    1. Muscarinic receptors mediating inhibition of gamma-aminobutyric acid release in rat corpus striatum and their pharmacological characterization.
      M Raiteri, M Marchi, P Paudice and A Pittaluga
      Journal of Pharmacology and Experimental Therapeutics August 1990, 254 (2) 496-501;

  13. Pond, S M

    1. Efficacy of single or repeated hemoperfusion in a canine model of paraquat poisoning.
      E C Hampson, D J Effeney and S M Pond
      Journal of Pharmacology and Experimental Therapeutics August 1990, 254 (2) 732-740;

  14. Porreca, F

    1. Modulation of the potency and efficacy of mu-mediated antinociception by delta agonists in the mouse.
      J N Qi, H I Mosberg and F Porreca
      Journal of Pharmacology and Experimental Therapeutics August 1990, 254 (2) 683-689;

  15. Potter, L T

    1. Effects of benzoyltropine and tropacocaine on several cholinergic processes in the rat brain.
      E M Meyer, L T Potter, C L De Vane, I Irwin, S L MacKay, R Miller and A J Ruttenber
      Journal of Pharmacology and Experimental Therapeutics August 1990, 254 (2) 584-590;

Q

  1. Qi, J N

    1. Modulation of the potency and efficacy of mu-mediated antinociception by delta agonists in the mouse.
      J N Qi, H I Mosberg and F Porreca
      Journal of Pharmacology and Experimental Therapeutics August 1990, 254 (2) 683-689;

R

  1. Raiteri, M

    1. Muscarinic receptors mediating inhibition of gamma-aminobutyric acid release in rat corpus striatum and their pharmacological characterization.
      M Raiteri, M Marchi, P Paudice and A Pittaluga
      Journal of Pharmacology and Experimental Therapeutics August 1990, 254 (2) 496-501;

  2. Ramlal, T

    1. Halothane increases cytosolic Ca2+ and inhibits Na+/H+ exchange in L6 muscle cells.
      A Klip, M Hill and T Ramlal
      Journal of Pharmacology and Experimental Therapeutics August 1990, 254 (2) 552-559;

  3. Rampart, M

    1. Pharmacological characterization of 5-hydroxytryptamine receptors in the canine terminal ileum and ileocolonic junction.
      G E Boeckxstaens, P A Pelckmans, M Rampart, J J Bogers, T J Verbeuren, A G Herman and Y M Van Maercke
      Journal of Pharmacology and Experimental Therapeutics August 1990, 254 (2) 652-658;
    2. Evidence against ATP being the inhibitory transmitter released by nonadrenergic noncholinergic nerves in the canine ileocolonic junction.
      G E Boeckxstaens, P A Pelckmans, M Rampart, T J Verbeuren, A G Herman and Y M Van Maercke
      Journal of Pharmacology and Experimental Therapeutics August 1990, 254 (2) 659-663;

  4. Ratz, P H

    1. Differential activation of rabbit femoral arteries by aluminum fluoride and sodium fluoride.
      P H Ratz and P F Blackmore
      Journal of Pharmacology and Experimental Therapeutics August 1990, 254 (2) 514-520;

  5. Reisine, T

    1. Cellular mechanisms of somatostatin inhibition of calcium influx in the anterior pituitary cell line AtT-20.
      T Reisine
      Journal of Pharmacology and Experimental Therapeutics August 1990, 254 (2) 646-651;

  6. Reynier-Rebuffel, A M

    1. Effects of methylene blue on hypoxic cerebral vasodilatation in the rabbit.
      W J Pearce, A M Reynier-Rebuffel, J Lee, P Aubineau, L Ignarro and J Seylaz
      Journal of Pharmacology and Experimental Therapeutics August 1990, 254 (2) 616-625;

  7. Ricci, A

    1. Autoradiographic localization of dopamine DA-2 receptor sites in rat mesenteric vascular tree.
      A Ricci and F Amenta
      Journal of Pharmacology and Experimental Therapeutics August 1990, 254 (2) 750-755;

  8. Ruffolo, R R

    1. Prevention and complete reversal of cyclosporine A-induced renal vasoconstriction and nephrotoxicity in the rat by fenoldopam.
      D P Brooks, D J Drutz and R R Ruffolo
      Journal of Pharmacology and Experimental Therapeutics August 1990, 254 (2) 375-379;

  9. Ruskoaho, H

    1. Mechanism of opioid-induced atrial natriuretic peptide release in conscious rats.
      A Pesonen, J Leppäluoto and H Ruskoaho
      Journal of Pharmacology and Experimental Therapeutics August 1990, 254 (2) 690-695;

  10. Ruttenber, A J

    1. Effects of benzoyltropine and tropacocaine on several cholinergic processes in the rat brain.
      E M Meyer, L T Potter, C L De Vane, I Irwin, S L MacKay, R Miller and A J Ruttenber
      Journal of Pharmacology and Experimental Therapeutics August 1990, 254 (2) 584-590;

S

  1. Sanders-Bush, E

    1. Adaptation of brain 5HT2 receptors after mianserin treatment: receptor sensitivity, not receptor binding, more accurately correlates with behavior.
      R L Smith, R J Barrett and E Sanders-Bush
      Journal of Pharmacology and Experimental Therapeutics August 1990, 254 (2) 484-488;

  2. Sanger, D J

    1. Effects of buspirone and related compounds on suppressed operant responding in rats.
      D J Sanger
      Journal of Pharmacology and Experimental Therapeutics August 1990, 254 (2) 420-426;

  3. Sariola, H

    1. Elevation of plasma atrial natriuretic peptide in rats with chronic heart failure by SCH 39370, a neutral metalloendopeptidase inhibitor.
      I Tikkanen, K Helin, T Tikkanen, E J Sybertz, S Vemulapalli, H Sariola, H Näveri and F Fyhrquist
      Journal of Pharmacology and Experimental Therapeutics August 1990, 254 (2) 641-645;

  4. Sasyniuk, B I

    1. Frequency and voltage-dependent effects of mono-N-dealkyldisopyramide, the major metabolite of disopyramide, in canine ventricular tissue.
      W Toy and B I Sasyniuk
      Journal of Pharmacology and Experimental Therapeutics August 1990, 254 (2) 603-611;

  5. Schmidt, H H

    1. Basal and stimulated formation and release of L-arginine-derived nitrogen oxides from cultured endothelial cells.
      H H Schmidt, B Zernikow, S Baeblich and E Böhme
      Journal of Pharmacology and Experimental Therapeutics August 1990, 254 (2) 591-597;

  6. Seylaz, J

    1. Effects of methylene blue on hypoxic cerebral vasodilatation in the rabbit.
      W J Pearce, A M Reynier-Rebuffel, J Lee, P Aubineau, L Ignarro and J Seylaz
      Journal of Pharmacology and Experimental Therapeutics August 1990, 254 (2) 616-625;

  7. Sivam, S P

    1. Compensatory activation of substance P biosynthesis by L-dihydroxyphenylalanine in striatonigral neurons of neonatal dopaminergic denervated rats.
      S P Sivam and J E Krause
      Journal of Pharmacology and Experimental Therapeutics August 1990, 254 (2) 433-439;

  8. Skupny, A

    1. Alcohol effects on hCG-stimulated gonadal hormones in women.
      S K Teoh, J H Mendelson, N K Mello, A Skupny and J Ellingboe
      Journal of Pharmacology and Experimental Therapeutics August 1990, 254 (2) 407-411;

  9. Smith, R L

    1. Adaptation of brain 5HT2 receptors after mianserin treatment: receptor sensitivity, not receptor binding, more accurately correlates with behavior.
      R L Smith, R J Barrett and E Sanders-Bush
      Journal of Pharmacology and Experimental Therapeutics August 1990, 254 (2) 484-488;

  10. Song, Z H

    1. Involvement of spinal kappa opioid receptors in the antinociception produced by intrathecally administered corticotropin-releasing factor in mice.
      Z H Song and A E Takemori
      Journal of Pharmacology and Experimental Therapeutics August 1990, 254 (2) 363-368;

  11. Steketee, J D

    1. Effect of microinjections of apamin into the A10 dopamine region of rats: a behavioral and neurochemical analysis.
      J D Steketee and P W Kalivas
      Journal of Pharmacology and Experimental Therapeutics August 1990, 254 (2) 711-719;

  12. Stevens, C W

    1. Interaction of intrathecal morphine and ST-91 on antinociception in the rat: dose-response analysis, antagonism and clearance.
      M S Monasky, A R Zinsmeister, C W Stevens and T L Yaksh
      Journal of Pharmacology and Experimental Therapeutics August 1990, 254 (2) 383-392;

  13. Sybertz, E J

    1. Elevation of plasma atrial natriuretic peptide in rats with chronic heart failure by SCH 39370, a neutral metalloendopeptidase inhibitor.
      I Tikkanen, K Helin, T Tikkanen, E J Sybertz, S Vemulapalli, H Sariola, H Näveri and F Fyhrquist
      Journal of Pharmacology and Experimental Therapeutics August 1990, 254 (2) 641-645;

T

  1. Takemori, A E

    1. Involvement of spinal kappa opioid receptors in the antinociception produced by intrathecally administered corticotropin-releasing factor in mice.
      Z H Song and A E Takemori
      Journal of Pharmacology and Experimental Therapeutics August 1990, 254 (2) 363-368;

  2. Takeuchi, K

    1. Characterization of alkaline response induced by cholinergic agents in the rat duodenum: involvement of M2 receptors and the calcium-dependent process.
      K Takeuchi, H Niida and S Okabe
      Journal of Pharmacology and Experimental Therapeutics August 1990, 254 (2) 465-470;

  3. Teoh, S K

    1. Alcohol effects on hCG-stimulated gonadal hormones in women.
      S K Teoh, J H Mendelson, N K Mello, A Skupny and J Ellingboe
      Journal of Pharmacology and Experimental Therapeutics August 1990, 254 (2) 407-411;

  4. Tikkanen, I

    1. Elevation of plasma atrial natriuretic peptide in rats with chronic heart failure by SCH 39370, a neutral metalloendopeptidase inhibitor.
      I Tikkanen, K Helin, T Tikkanen, E J Sybertz, S Vemulapalli, H Sariola, H Näveri and F Fyhrquist
      Journal of Pharmacology and Experimental Therapeutics August 1990, 254 (2) 641-645;

  5. Tikkanen, T

    1. Elevation of plasma atrial natriuretic peptide in rats with chronic heart failure by SCH 39370, a neutral metalloendopeptidase inhibitor.
      I Tikkanen, K Helin, T Tikkanen, E J Sybertz, S Vemulapalli, H Sariola, H Näveri and F Fyhrquist
      Journal of Pharmacology and Experimental Therapeutics August 1990, 254 (2) 641-645;

  6. Toy, W

    1. Frequency and voltage-dependent effects of mono-N-dealkyldisopyramide, the major metabolite of disopyramide, in canine ventricular tissue.
      W Toy and B I Sasyniuk
      Journal of Pharmacology and Experimental Therapeutics August 1990, 254 (2) 603-611;

  7. Tytgat, J

    1. Mechanism of cardiac T-type Ca channel blockade by amiloride.
      J Tytgat, J Vereecke and E Carmeliet
      Journal of Pharmacology and Experimental Therapeutics August 1990, 254 (2) 546-551;

U

  1. Unger, S E

    1. Metabolism of methylenedioxymethamphetamine: formation of dihydroxymethamphetamine and a quinone identified as its glutathione adduct.
      M Hiramatsu, Y Kumagai, S E Unger and A K Cho
      Journal of Pharmacology and Experimental Therapeutics August 1990, 254 (2) 521-527;

V

  1. Van Maercke, Y M

    1. Pharmacological characterization of 5-hydroxytryptamine receptors in the canine terminal ileum and ileocolonic junction.
      G E Boeckxstaens, P A Pelckmans, M Rampart, J J Bogers, T J Verbeuren, A G Herman and Y M Van Maercke
      Journal of Pharmacology and Experimental Therapeutics August 1990, 254 (2) 652-658;
    2. Evidence against ATP being the inhibitory transmitter released by nonadrenergic noncholinergic nerves in the canine ileocolonic junction.
      G E Boeckxstaens, P A Pelckmans, M Rampart, T J Verbeuren, A G Herman and Y M Van Maercke
      Journal of Pharmacology and Experimental Therapeutics August 1990, 254 (2) 659-663;

  2. Veldet, C

    1. Alpha-adrenoceptor mediated facilitation of acetylcholine release in the rat perfused heart.
      I T Bognar, R Baretti, S Fischer, C Veldet and H Fuder
      Journal of Pharmacology and Experimental Therapeutics August 1990, 254 (2) 702-710;

  3. Vemulapalli, S

    1. Elevation of plasma atrial natriuretic peptide in rats with chronic heart failure by SCH 39370, a neutral metalloendopeptidase inhibitor.
      I Tikkanen, K Helin, T Tikkanen, E J Sybertz, S Vemulapalli, H Sariola, H Näveri and F Fyhrquist
      Journal of Pharmacology and Experimental Therapeutics August 1990, 254 (2) 641-645;

  4. Verbeuren, T J

    1. Pharmacological characterization of 5-hydroxytryptamine receptors in the canine terminal ileum and ileocolonic junction.
      G E Boeckxstaens, P A Pelckmans, M Rampart, J J Bogers, T J Verbeuren, A G Herman and Y M Van Maercke
      Journal of Pharmacology and Experimental Therapeutics August 1990, 254 (2) 652-658;
    2. Evidence against ATP being the inhibitory transmitter released by nonadrenergic noncholinergic nerves in the canine ileocolonic junction.
      G E Boeckxstaens, P A Pelckmans, M Rampart, T J Verbeuren, A G Herman and Y M Van Maercke
      Journal of Pharmacology and Experimental Therapeutics August 1990, 254 (2) 659-663;

  5. Vereecke, J

    1. Mechanism of cardiac T-type Ca channel blockade by amiloride.
      J Tytgat, J Vereecke and E Carmeliet
      Journal of Pharmacology and Experimental Therapeutics August 1990, 254 (2) 546-551;

  6. Vogelsang, G D

    1. U-66444B and U-68553B, potent autoreceptor agonists at dopaminergic cell bodies and terminals.
      M F Piercey, P A Broderick, W E Hoffmann and G D Vogelsang
      Journal of Pharmacology and Experimental Therapeutics August 1990, 254 (2) 369-374;

W

  1. Weiner, N

    1. Ca2(+)-evoked [3H]dopamine release from synaptosomes is dependent on neuronal type Ca2+ channels and is not mediated by acetylcholine, glutamate or aspartate release.
      J F Bowyer and N Weiner
      Journal of Pharmacology and Experimental Therapeutics August 1990, 254 (2) 664-670;

  2. Wing, L L

    1. Serotonin release contributes to the locomotor stimulant effects of 3,4-methylenedioxymethamphetamine in rats.
      C W Callaway, L L Wing and M A Geyer
      Journal of Pharmacology and Experimental Therapeutics August 1990, 254 (2) 456-464;

  3. Wong, D D

    1. Bioactivation of 8-methoxypsoralen and irreversible inactivation of cytochrome P-450 in mouse liver microsomes: modification by monoclonal antibodies, inhibition of drug metabolism and distribution of covalent adducts.
      D C Mays, J B Hilliard, D D Wong, M A Chambers, S S Park, H V Gelboin and N Gerber
      Journal of Pharmacology and Experimental Therapeutics August 1990, 254 (2) 720-731;

  4. Woods, J H

    1. Discriminative stimulus effects of opioid agonists in morphine-dependent pigeons.
      C P France and J H Woods
      Journal of Pharmacology and Experimental Therapeutics August 1990, 254 (2) 626-632;

  5. Wyss, P A

    1. Single-dose kinetics of tissue distribution, excretion and metabolism of amiodarone in rats.
      P A Wyss, M J Moor and M H Bickel
      Journal of Pharmacology and Experimental Therapeutics August 1990, 254 (2) 502-507;

Y

  1. Yaksh, T L

    1. Interaction of intrathecal morphine and ST-91 on antinociception in the rat: dose-response analysis, antagonism and clearance.
      M S Monasky, A R Zinsmeister, C W Stevens and T L Yaksh
      Journal of Pharmacology and Experimental Therapeutics August 1990, 254 (2) 383-392;

  2. Yamamoto, T

    1. Effect of UDP-glucuronic acid depletion by salicylamide on biliary bilirubin excretion in the rat.
      T Kamisako, Y Adachi and T Yamamoto
      Journal of Pharmacology and Experimental Therapeutics August 1990, 254 (2) 380-382;

  3. Youssefyeh, R D

    1. RG 12915: a potent 5-hydroxytryptamine-3 antagonist that is an orally effective inhibitor of cytotoxic drug-induced emesis in the ferret and dog.
      L R Fitzpatrick, R M Lambert, C E Pendley, G E Martin, J S Bostwick, G W Gessner, J E Airey, R D Youssefyeh, R G Pendleton and D L Decktor
      Journal of Pharmacology and Experimental Therapeutics August 1990, 254 (2) 450-455;

Z

  1. Zernikow, B

    1. Basal and stimulated formation and release of L-arginine-derived nitrogen oxides from cultured endothelial cells.
      H H Schmidt, B Zernikow, S Baeblich and E Böhme
      Journal of Pharmacology and Experimental Therapeutics August 1990, 254 (2) 591-597;

  2. Zinsmeister, A R

    1. Interaction of intrathecal morphine and ST-91 on antinociception in the rat: dose-response analysis, antagonism and clearance.
      M S Monasky, A R Zinsmeister, C W Stevens and T L Yaksh
      Journal of Pharmacology and Experimental Therapeutics August 1990, 254 (2) 383-392;
Back to top

In this issue